Dx Deals: Labcorp Acquires Stake in European Testing Giant
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Is Sales Training Really Needed in the Lab Industry?
Why ongoing coaching and learning is required for laboratory sales reps—even experienced ones—to help labs meet their business goals
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report
After a slow August, product launches were up in volume but not dramatic impact. Here's a rundown of the new diagnostics to hit the market in…
The End Comes for Theranos
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
FDA Watch: New LDT Proposal Is Much Different from One Negotiated with Industry
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Artificial Intelligence: An Automated New World for Labs & Pathology
From - Laboratory Industry Report
Artificial intelligence (AI) and machine learning are making significant inroads in the diagnostics realm. Here are four ways…
Toxicology Laboratories Play Key Role in Curbing the Drug Addiction and Opioid Epidemic
From - Laboratory Industry Report
The National Independent Laboratory Association's (NILA's) Opioid Task Force is releasing a white paper entitled…
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
From - Laboratory Industry Report
After a busy July, the pace and volume of new product launches slowed significantly in August…
FDA Watch: Lab Industry Objects to Agency’s New LDT Proposal
From - Laboratory Industry Report
On Aug. 3, the Food and Drug Administration heated the long simmering controversy over FDA regulation of laboratory developed tests (LDTs) to full boil by submitting…
DX Earnings Report: Q2 Lab Earnings Stay Strong but Not Quite at Q1 Levels
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
From - Laboratory Industry Report
Forget the lazy days of summer–lab companies have been moving forward with deals. Here's a look at key activity from…
Cost Avoidance vs Cost Savings: What’s the Difference?
By Jennifer Dawson, MHA, DLM (ASCP) bio
As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to demonstrate…